Answer
Dalbavancin kills susceptible Gram-positive bacteria by binding to terminal D-alanyl-D-alanine in developing cell-wall peptidoglycan, preventing cross-linking and interrupting cell-wall synthesis.
Sources for this answer
- Xydalba 500 mg powder for concentrate for solution for infusionADVANZ Pharma · emc · SmPC §5.1 Pharmacodynamic properties · Version 8Document updated
Sources checked